Xuanling Shi

13.2k total citations · 2 hit papers
50 papers, 6.0k citations indexed

About

Xuanling Shi is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Xuanling Shi has authored 50 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Infectious Diseases, 17 papers in Virology and 15 papers in Molecular Biology. Recurrent topics in Xuanling Shi's work include HIV Research and Treatment (17 papers), SARS-CoV-2 and COVID-19 Research (16 papers) and Animal Virus Infections Studies (9 papers). Xuanling Shi is often cited by papers focused on HIV Research and Treatment (17 papers), SARS-CoV-2 and COVID-19 Research (16 papers) and Animal Virus Infections Studies (9 papers). Xuanling Shi collaborates with scholars based in China, United States and South Korea. Xuanling Shi's co-authors include Linqi Zhang, Xinquan Wang, Qi Zhang, Sisi Shan, Jun Lan, Jiwan Ge, Shilong Fan, Jinfang Yu, Qisheng Wang and Huan Zhou and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Xuanling Shi

49 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

2020 4.0k citations Jun Lan, Jinfang Yu et al. profile →
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4

2013 519 citations Xuanling Shi, Liwei Jiang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xuanling Shi China	22	4.7k	1.7k	815	742	617	50	6.0k
Ching‐Lin Hsieh United States	19	5.2k 1.1×	1.7k 1.0×	573 0.7×	630 0.8×	607 1.0×	30	6.7k
Guangwen Lu China	32	4.7k 1.0×	1.6k 0.9×	1.2k 1.5×	533 0.7×	920 1.5×	84	6.4k
Abigail Wall United States	8	5.4k 1.2×	1.7k 1.0×	594 0.7×	707 1.0×	498 0.8×	11	6.7k
Qibin Geng United States	17	4.8k 1.0×	1.3k 0.8×	747 0.9×	615 0.8×	452 0.7×	28	5.9k
Olubukola M. Abiona United States	6	4.9k 1.0×	1.5k 0.9×	533 0.7×	616 0.8×	452 0.7×	8	6.0k
Jory A. Goldsmith United States	10	5.5k 1.2×	2.0k 1.2×	602 0.7×	708 1.0×	561 0.9×	14	6.9k
Qisheng Wang China	18	5.2k 1.1×	2.5k 1.5×	569 0.7×	1.3k 1.8×	495 0.8×	60	7.6k
Kizzmekia S. Corbett United States	16	6.7k 1.4×	2.1k 1.2×	975 1.2×	741 1.0×	718 1.2×	23	8.2k
Huan Zhou China	28	5.1k 1.1×	3.0k 1.8×	580 0.7×	1.2k 1.6×	517 0.8×	141	8.7k

Countries citing papers authored by Xuanling Shi

Since Specialization

Citations

This map shows the geographic impact of Xuanling Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuanling Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuanling Shi more than expected).

Fields of papers citing papers by Xuanling Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuanling Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuanling Shi. The network helps show where Xuanling Shi may publish in the future.

Co-authorship network of co-authors of Xuanling Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Xuanling Shi. A scholar is included among the top collaborators of Xuanling Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuanling Shi. Xuanling Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yangyang, Ying Hou, Xiaoyu Liu, et al.. (2023). Novel TLR7/8 agonists promote activation of HIV-1 latent reservoirs and human T and NK cells. Frontiers in Microbiology. 14. 1033448–1033448. 6 indexed citations

Wang, Ruoke, Qi Zhang, Rui Zhang, et al.. (2022). SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2. Frontiers in Immunology. 13. 854952–854952. 14 indexed citations

Zhu, Qian‐Ying, Sisi Shan, Jinfang Yu, et al.. (2021). A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus. Nature Communications. 12(1). 6624–6624. 25 indexed citations

Liu, Xiaoshuang, Guanqiao Li, Xian Xu, et al.. (2021). Differential impact of non-pharmaceutical public health interventions on COVID-19 epidemics in the United States. BMC Public Health. 21(1). 965–965. 21 indexed citations

Li, Guanqiao, Xi Lu, Xiang Li, et al.. (2021). Role of efficient testing and contact tracing in mitigating the COVID-19 pandemic: a network modelling study. BMJ Open. 11(7). e045886–e045886. 9 indexed citations

Shan, Sisi, Chee Keng Mok, Shuyuan Zhang, et al.. (2021). A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants. Frontiers in Immunology. 12. 766821–766821. 11 indexed citations

Wang, Qian, Bingting Ma, Angqi Zhu, et al.. (2020). Stabilized diverse HIV-1 envelope trimers for vaccine design. Emerging Microbes & Infections. 9(1). 775–786. 9 indexed citations

Li, Hongyue, Chaoyue Zhao, Yuhang Zhang, et al.. (2020). Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays. Emerging Microbes & Infections. 9(1). 2269–2277. 28 indexed citations

Xu, Jiuyang, Wenxu Jia, Pengfei Wang, et al.. (2019). Antibodies and vaccines against Middle East respiratory syndrome coronavirus. Emerging Microbes & Infections. 8(1). 841–856. 60 indexed citations

10.

Jia, Wenxu, Rudragouda Channappanavar, Chao Zhang, et al.. (2019). Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection. Emerging Microbes & Infections. 8(1). 760–772. 29 indexed citations

11.

Wang, Qian, Lihong Liu, Wuze Ren, et al.. (2019). A Single Substitution in gp41 Modulates the Neutralization Profile of SHIV during In Vivo Adaptation. Cell Reports. 27(9). 2593–2607.e5. 7 indexed citations

12.

Gao, Fei, Xiaohe Lin, Linling He, et al.. (2019). Development of a Potent and Protective Germline-Like Antibody Lineage Against Zika Virus in a Convalescent Human. Frontiers in Immunology. 10. 2424–2424. 13 indexed citations

13.

Hu, Hailin, An Xiao, Sai Zhang, et al.. (2018). DeepHINT: understanding HIV-1 integration via deep learning with attention. Bioinformatics. 35(10). 1660–1667. 38 indexed citations

14.

Fu, Lili, et al.. (2018). Synthesis and Anti-HIV-1 Activity of Stapled HIV-1 Fusion Inhibitors. Chinese Journal of Organic Chemistry. 38(5). 1267–1267. 2 indexed citations

15.

Zhang, Senyan, Pan-Pan Zhou, Pengfei Wang, et al.. (2018). Structural Definition of a Unique Neutralization Epitope on the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein. Cell Reports. 24(2). 441–452. 47 indexed citations

16.

Wang, Qian, Hua Wang, Xuanling Shi, et al.. (2016). Spatiotemporal hierarchy in antibody recognition against transmitted HIV-1 envelope glycoprotein during natural infection. Retrovirology. 13(1). 12–12. 6 indexed citations

17.

Li, Lan, Xuanling Shi, Senyan Zhang, et al.. (2012). Role of Human CD4 D1D2 Domain in HIV-1 Infection. Immunological Investigations. 42(2). 106–121. 2 indexed citations

18.

Shang, Hong, Xiaoxu Han, Xuanling Shi, et al.. (2011). Genetic and Neutralization Sensitivity of Diverse HIV-1 env Clones from Chronically Infected Patients in China. Journal of Biological Chemistry. 286(16). 14531–14541. 44 indexed citations

19.

Das, Supratik, Sheeba Mathew, Xuhong Wu, et al.. (2009). Recruitment of a SAP18-HDAC1 Complex into HIV-1 Virions and Its Requirement for Viral Replication. PLoS Pathogens. 5(6). e1000463–e1000463. 51 indexed citations

20.

Nie, Yuchun, Peigang Wang, Xuanling Shi, et al.. (2004). Highly infectious SARS-CoV pseudotyped virus reveals the cell tropism and its correlation with receptor expression. Biochemical and Biophysical Research Communications. 321(4). 994–1000. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact